Oncology

New treatment for multiple myeloma

The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of  adult patients with multiple myeloma. Isatuximab-irfc was previously designated its orphan drug status by the FDA. Isatuximab-irfc was approved...

Study examines rate of cancer overdiagnosis in Australia

A recent study published in the Medical Journal of Australia examined the “proportion of cancer diagnoses in Australia that might reasonably be attributed to overdiagnosis.” The research team collected data between 1982 and 2012 from...

New vaccine eliminated breast cancer in first human patient

A vaccine being developed in the Mayo Clinic in Jacksonville, Florida is aimed at preventing new cases of ovarian and breast cancer and even recurring cases of these cancers. The vaccine is currently being tested,...

The World Health Organization aims to reduce mortality of cervical cancer

In a recent study, the World Health Organization (WHO) describes a study which aims to eliminate cervical cancer “as a public health problem.” This goal is planned to be achieved through the WHO’s Cervical Cancer...

New treatment for advanced epithelioid sarcoma

The U.S. Food and Drug Administration (FDA) recently approved Epizyme, Inc’s tazemetostat (TAZVERIK) for the treatment of adult and pediatric patients with metastatic or advanced epithelioid sarcoma (AES). AES is a rare sarcoma that affects...

Take Care of Yourself

How many of you hear the phrase “self-care” and roll your eyes? I know. Because that’s my reaction, too. As if nurses’ endless task lists can accommodate one more thing: to take care of...

New findings from the American Cancer Society on reduced cancer mortality rates

Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between 1991 to 2017 in the US. Additionally, between 2016 to 2017, there was a...

Oncology nursing core competencies

As more patients survive cancer, nursing education must meet the demand for nurses who can care for them. Takeaways At the same time that death rates from cancer continue to decline, the numbers of cancer...

Accelerated approval for new sickle cell disease treatment

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to Global Blood Therapeutics’ voxelotor (Oxbryta), a treatment for adults and pediatric patients (12 years and older) with sickle cell disease (SCD). SCD is...

Pragmatic dissemination and implementation hybrid research

Innovative study designs examine implementation and generate new knowledge. Takeaways:  Some organizations struggle to meet Magnet® nurse research requirements.  Many research efforts result in applying evidence or quality improvement efforts but don’t create new knowledge.  ...

Accelerated approval for a new mantle cell lymphoma drug

The Food and Drug Administration (FDA) has recently granted accelerated approval to BeiGene’s mantle cell lymphoma (MCL) oral therapy, zanubritinib (BRUKINSA). Zanubritinib’s efficacy was examined through a phase 2 clinical trial (BGB-311-206 / NCT0306970) in...

American Heart Association: E-cigarettes are not safe alternative

The American Heart Association (AHA) recently held its 2019 Scientific Sessions in Philadelphia PA. The sessions covered many topics, but one of the most impactful was a session on e-cigarettes and their adverse health...

New guidelines for exercise during cancer treatment

The American College of Sports Medicine (ACSM) recently released new guidelines for exercise prescriptions while patients are undergoing cancer treatment. The updated guidelines include the following points: Exercise is an important tool for cancer prevention,...